SUMO1 and rheumatoid arthritis: One example is identifying the peripheral blood cell biomarkers SUMO1 (Small ubiquitin-like modifier 1) and POU2AF1 (POU domain class 2-associating Factor 1), which have decreased expression in patients with RA compared to first-degree relatives and negatively correlate with disease progression and ACPA levels [11].